Longevity Investors & VC Firms in New York
19 firms in this list, with a median first check of $500K. 6 of them lead rounds. Generated from verified public data and updated continuously.
OrbiMed
New YorkPre-Seed–Late Stage$1M – $75M
126 people
AlleyCorp
New YorkPre-Seed–Series A$1M – $5M
37 people
Catalio Capital Management, LP
New YorkSeed–Late Stage
41 people
Casdin Capital
New YorkSeed–Series C
39 people
StartUp Health
New YorkSeed
42 people
Everywhere Ventures
New YorkPre-Seed–Seed$250K
7 people
2048 Ventures
New YorkPre-Seed–Seed$500K – $3M
11 people
Digitalis Ventures
New YorkSeed–Late Stage$100K – $10M
18 people
Primetime Partners
New YorkSeed–Series A$250K – $1M
15 people
Able Partners
New York CitySeed–Series A$500K – $3M
3 people
Black Jays Ventures
New YorkPre-Seed–Seed$50K – $250K
4 people
Medical Excellence Capital
New YorkPre-Seed–Series B
17 people
Kinled Holding
Hong KongSeed–Series A
1 person
Easton Capital
New YorkSeed–Late Stage$10M – $20M
7 people
Blackstone Life Sciences
New YorkSeries A–Late Stage$20M – $60M
9 people
Averin Capital
New YorkSeed–Growth
9 people
Later Capital
New YorkPre-Seed–Seed
5 people
Astor Perkins
New YorkSeed–Late Stage
2 people
Proton Enterprises
New YorkSeed–Series A
1 person
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.



































.png)




















